Popular Articles

Many Washington State Hospitals Skimp On Required Charity Care
"As the recession has cost more people their jobs and their health insurance, local hospitals have seen more patients show up with no way to pay," reports KUOW, a Washington State public radio station. "Hospitals in Washington are required to provide free care to anyone living below the poverty line, if they ask for it. But some hospitals give more freely than others."
generic viagra
NACDS To Honor Len DeMino At NACDS Pharmacy & Technology Conference As Industry Icon Announces Retirement As Consultant To The Association
The National Association of Chain Drug Stores (NACDS) today announced that the 2009 NACDS Pharmacy & Technology Conference will provide a forum at which to provide further recognition to Leonard J. DeMino, RPh., a chain pharmacy icon whose resume already includes some of the industry"s highest honors and achievements. This news comes as DeMino announces his retirement as senior pharmacy consultant to NACDS, effective in June 2009.
Zubni implantati
News of the day
U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as an adjunct to diet and exercise to improve blood sugar (glycemic) control in adults for the treatment of type 2 diabetes mellitus. ONGLYZA once daily can be used in combination with commonly prescribed oral anti-diabetic medications metformin, sulfonylureas or thiazolidinediones (TZD) or as a monotherapy to significantly reduce glycosylated hemoglobin (A1C) levels. ONGLYZA should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis (high levels of certain acids, known as ketones, in the blood or urine). ONGLYZA has not been studied in combination with insulin.
Oncology

British Medical Journal Group Provides Medical Information For Doctors On The Move

Health professionals across the world can now get on-the-spot access to expert opinion, guidelines and the latest clinical evidence on their mobile phone. This service is being made available at no extra cost to all subscribers of Best Practice, the new on-line decision support tool designed to help practitioners, medical students and researchers find the best medical information and use it in the most effective way. Built specifically for point-of-care use it helps meet the real, diverse and evolving information challenges that health professionals face every day whether in the surgery, hospital or out in the community. "For doctors on the move, having immediate access to reliable information is a real bonus for busy clinicians seeking to deliver evidence-based health care", says Dr Charles Young, Best Practice Editor in Chief. "Doctors now have a reliable second opinion in an instant - anywhere, anytime." This facility has been made possible through a joint agreement with Mobile IQ, enabling the BMJ Group to benefit from Mobile IQ"s award winning mobile publishing platform, Fabric. This allows access to any content contained in Best Practice on any mobile device and the information is fully searchable to ensure easy navigation of the material. Fabric also supports links between mobile devices and e-mails so that, for example, doctors who find an interesting article whilst on the phone can email it to themselves and read it later at their desk. "Mobile IQ is delighted to be powering the BMJ Group"s mobile strategy, enabling them to rapidly deliver their content in new and innovative ways," said Shaun Barriball, Managing Director of Mobile IQ. "This partnership demonstrates that mobile is maturing and being embraced by enterprises to deliver critical information." Best Practice covers 10,000 diagnoses and all content is written and peer reviewed by internationally renowned specialists. It provides critical prescribing information, guideline summaries and expert opinion together with advice on symptom evaluation, test ordering and treatment strategies. Best Practice Mobile is at: http://bp.bmjgroup.mobi British Medical Journal


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):